Form 144: 17,564 CGON Shares Proposed for Sale

James Mule filed a Form 144 proposing the sale of 17,564 shares of Common stock on 04/17/2026.

Rhea-AI Filing Summary

James Mule filed a Form 144 proposing the sale of 17,564 shares of Common stock on 04/17/2026. The sale is listed as an Exercise of Stock Options with cash proceeds. The filing also shows prior 10b5-1 sales of 1,964 shares on 03/16/2026 for $124,714.

Insights

Corporate Transactions Analyst

Routine Rule 144 resale notice tied to option exercise and prior 10b5-1 sales.

The filing lists a proposed sale of 17,564 shares on 04/17/2026 arising from an exercise of stock options that will be settled for cash. It notes a separate 10b5-1 sale of 1,964 shares on 03/16/2026 for $124,714.

Cash‑flow treatment is explicit for the option exercise (cash). This is a routine insider liquidity filing; timing and market impact depend on actual sale execution and market liquidity.

Key Figures

Proposed shares to be sold: 17,564 shares Prior 10b5-1 shares sold: 1,964 shares Proceeds from prior sale: $124,714 +2 more

5 metrics

Proposed shares to be sold 17,564 shares proposed sale on 04/17/2026 from exercise of stock options

Prior 10b5-1 shares sold 1,964 shares sale on 03/16/2026 under a 10b5-1 plan

Proceeds from prior sale $124,714 proceeds reported for 1,964 shares sold on 03/16/2026

Broker/Dealer listed Morgan Stanley Smith Barney LLC identified for securities to be sold (New York address)

Filing date for proposed sale 04/17/2026 date listed for the proposed 17,564-share sale

Key Terms

Form 144, 10b5-1, Exercise of Stock Options

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for JAMES MULE 400 CENTER DRIVE"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | Common | 04/17/2026 | Exercise of Stock Options"

FAQ

What does James Mule's Form 144 for CGON disclose?

It discloses a proposed sale of 17,564 shares of Common stock on 04/17/2026, listed as an exercise of stock options settled for cash. The filing also lists prior 10b5-1 sales of 1,964 shares on 03/16/2026.

How many shares were sold under the 10b5-1 plan in the prior three months for CGON?

The filing shows 1,964 shares sold on 03/16/2026 pursuant to a 10b5-1 plan. Those sales generated $124,714 in proceeds as recorded in the disclosure.

What is the sale method and payment for the 17,564 shares in the CGON filing?

The 17,564 shares are tied to an exercise of stock options and are indicated to be settled for cash on 04/17/2026, per the Form 144 entry labeled "Cash."

Does the Form 144 indicate who will handle the sale for CGON shares?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services with an address in New York, suggesting a broker/dealer is involved in processing or facilitating the reported transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001684531
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CG Oncology, Inc.
SEC File Number	001-41925
Address of Issuer	400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CALIFORNIA 92618
Phone	9494093700
Name of Person for Whose Account the Securities are To Be Sold	JAMES MULE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17564	1165195.76	84435200	04/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/17/2026	Exercise of Stock Options	Issuer			17564	04/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES MULE 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618	Common	03/16/2026	1964	124714.00

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	04/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Mule
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)